We have located links that may give you full text access.
Evaluation Studies
Journal Article
Fusion 3-Dimensional Angiography of Both Internal Carotid Arteries in the Evaluation of Anterior Communicating Artery Aneurysms.
World Neurosurgery 2017 Februrary
BACKGROUND: To determine whether fusion 3-dimensional (3D) angiography of both internal carotid arteries can better disclose vascular details in patients diagnosed with anterior communicating artery (ACoA) aneurysms by computed tomography angiography (CTA) or magnetic resonance angiography (MRA).
METHODS: Thirty-eight patients diagnosed with ACoA aneurysms by CTA or MRA were evaluated by the new postprocessing feature, fusion 3D angiography, with results individually interpreted by 4 experts. Those experts compared fusion 3D angiography with dominant A1 side single 3D angiography to define advantages and disadvantages for ACoA aneurysms. Patients with unilateral A1 aplasia or rudimentary A1 were excluded. Patients who showed any disadvantages with this additional feature were classified as group 1, those with no advantages were classified as group 2, those with 1 or 2 advantages were classified as group 3, and those with 3 or more advantages were classified as group 4. Radiologic and clinical results were also evaluated.
RESULTS: Of the 38 patients, 33 (87%) benefited from fusion 3D angiography, including 17 in group 3 and 16 in group 4; of the remaining patients, 1 was classified as group 1 and 4 were classified as group 2. Representative 5 categories of advantage to fusion angiography were found and summarized by the 4 experts. All 33 patients showed defining the exact anatomy of the ACoA, and 22 (67%) showed full angiographic features of A2 or A3, including branches.
CONCLUSIONS: Fusion 3D angiography can significantly contribute to a better understanding of the complex anatomy of the anterior cerebral artery-ACoA complex, which is essential for successful treatment planning for ACoA aneurysms.
METHODS: Thirty-eight patients diagnosed with ACoA aneurysms by CTA or MRA were evaluated by the new postprocessing feature, fusion 3D angiography, with results individually interpreted by 4 experts. Those experts compared fusion 3D angiography with dominant A1 side single 3D angiography to define advantages and disadvantages for ACoA aneurysms. Patients with unilateral A1 aplasia or rudimentary A1 were excluded. Patients who showed any disadvantages with this additional feature were classified as group 1, those with no advantages were classified as group 2, those with 1 or 2 advantages were classified as group 3, and those with 3 or more advantages were classified as group 4. Radiologic and clinical results were also evaluated.
RESULTS: Of the 38 patients, 33 (87%) benefited from fusion 3D angiography, including 17 in group 3 and 16 in group 4; of the remaining patients, 1 was classified as group 1 and 4 were classified as group 2. Representative 5 categories of advantage to fusion angiography were found and summarized by the 4 experts. All 33 patients showed defining the exact anatomy of the ACoA, and 22 (67%) showed full angiographic features of A2 or A3, including branches.
CONCLUSIONS: Fusion 3D angiography can significantly contribute to a better understanding of the complex anatomy of the anterior cerebral artery-ACoA complex, which is essential for successful treatment planning for ACoA aneurysms.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app